California Cancer Reporting System Standards, Volume III

IF1204: TNM Path N, SSF 3, 4, 5 Breast (COC)

OWNER

CoC

EDIT SETS

California Hospital Transmit

Eureka Admission Level

Eureka Tumor Level

FIELDS

TNM Path N [NAACCR #890]

CS Site-Specific Factor 3 [NAACCR #2900]

CS Site-Specific Factor 4 [NAACCR #2910]

CS Site-Specific Factor 5 [NAACCR #2920]

Primary Site [NAACCR #400]

Histologic Type ICD-O-3 [NAACCR #522]

Behavior Code ICD-O-3 [NAACCR# 523]

TNM Clin N [NAACCR #950]

Date of Diagnosis [NAACCR #390]

Type of Reporting Source [NAACCR# 500]

 

TABLE

BREAST45.DBF

MESSAGE

  1. IF1204: TNM Path N [value], CS Site-Specific Factor 4 [value], and CS Site-Specific Factor 5 [value] conflict

  2. IF1204: Conflict between TNM Path N [value] and CS Site-Specific Factor 3 [value]

specification

Purpose: This edit verifies for primary site of breast that pathologic TNM N must be consistent with CS SSF 3 (Number of positive ipsilateral level I-II Axillary Lymph Nodes), CS SSF 4 (Immunohistochemistry of Regional Lymph Nodes), and CS SSF 5 (Molecular Studies of Regional Lymph Nodes).

 

This edit is skipped if any of the following conditions are true:

  1. Year of Date of Diagnosis is less than 2016, blank (unknown), or invalid

  2. Type of Reporting Source = 7 (Death Certificate Only)

  3. Behavior Code ICD-O-3 = 0 (benign) or 1 (borderline)

  4. Site/histology group not = 032, Breast.

  5. TNM Path N is blank or 88.

  6. TNM Path Descriptor = 4 or 6 (classification after neoadjuvant treatment)

  7. TNM Edition Number not = 07, U7

 

The site/histology groups are identified by site and histology in the edit Primary Site, Stage Group 2016 - Ed 7.

 

For CS Site-Specific Factor 3:

 

  1. If TNM Path N = p0, p0I-, p0I+, p0M-, p0M+,

then CS SSF 3 must = 000 (All ipsilateral axillary nodes examined negative).

  1. If TNM Path N = c0 or pX,

then CS SSF 3 must = 097 (Positive nodes, number unspecified), 098 (No axillary nodes examined), or 099 (Unknown if axillary nodes are positive).

 

For CS Site-Specific Factor 4, CS Site-Specific Factor 5:

 

  1. TNM Path N is compared to the combination of CS SSF 4 and CS SSF 5 using a table lookup.  Findings on molecular studies (CS SSF 5) are given precedence to findings on IHC studies (CS SSF 4). An error is generated if the combination of CS SSF 4 and CS SSF 5 do not support the assigned pN category.  If either CS SSF 4 or CS SSF 5 is coded 988, TNM N is compared to the value of the CS SSF not coded 988.  If  both are coded 988, the edit check is skipped.  If either CS SSF 4 or CS SSF 5 is blank (not coded), TNM N is compared to the value of the coded CS SSF. If both are blank, the edit check is skipped.

 

Three situations not handled by table lookup are included in the edit logic:

 

historical changes

In the SEER*Edits software, the title of this edit is: IF574.

08/2016

Per NAACCR v16, new edit added.

09/2016

Per NAACCR v16A:

  • Description updated to note that two situations not handled by table lookup are included in the edit logic:

    • The edit passes for TNM Path N = pX, CS SSF 4 = 987, CS SSF 5 = 987.

    • The edit passes for TNM Path N = c0, CS SSF 4 = 000, CS SSF 5 = 000.

  • Logic updated to pass when path N = c0, SSF4 = 000, SSF 5 = 000.

11/2016

Per NAACCR v16B:

  • Edit description, logic modified to pass if TNM Path Descriptor = 4 or 6.

11/2016

Per NAACCR v16C:

  • Description modified to note that third situation not handled by table lookup is included in edit logic:

  • The edit passes for TNM Path N = pX, TNM Clin N = c0, CS SSF 4 = 000, CS SSF 5 = 000.

  • Logic updated to pass when TNM Path N = pX, TNM Clin N = c0, CS SSF4 = 000, CS SSF 5 = 000.

03/2017

Per NAACCR v16D:

  • Added skip if TNM Edition Number not = 07,U7.

  • Modified description, logic to inlude 097 as allowable code with TNM Path N of c0 or pX.